Recent estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 have drawn attention to Lebanon's apparent ranking as the country with the largest increase in cancer ...
Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment When scientists sequence tumor DNA, ...
Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...
AI-detected extranodal extension could help predict which patients with oropharyngeal carcinoma would benefit from ...
Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable ...
The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...
Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...
The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...
The study’s findings track with recent research on the alarming rise of the cancer in younger adults. By Alice Callahan About 15 years ago, Dr. Andrew T. Chan, a gastroenterologist at Mass General ...